Evvy Raises $40M to Fix Women's Health Diagnostics

AI startup Evvy, officially Allora Health Inc., has closed a $40 million Series B round led by Catalio Capital Management to scale its precision diagnostics platform for women's health. The funding includes participation from the U.S. Fertility Innovation Fund, Rethink Impact, General Catalyst and others. Evvy's platform uses at-home metagenomic testing kits and a machine learning engine called EvvyAI to deliver personalized treatment plans. Built on the world's largest clinical-grade vaginal microbiome dataset, it has served over 100,000 patients, reduced bacterial vaginosis recurrence by 50%, and identified six distinct BV subtypes. The company plans to expand into fertility and broader women's health conditions.